This prospective, multicenter study aims to evaluate the relevance of anti-CD146 autoantibodies (AACD146) as biological markers for the early diagnosis of pulmonary diseases related to occupational exposure to silica. Silica exposure is a recognized risk factor for fibrotic, inflammatory, and cancerous respiratory diseases. Currently, no specific biological marker exists. The hypothesis is that AACD146 reflects early effects of silica exposure. The study will include 110 participants divided into two groups (exposed vs. non-exposed) and will compare AACD146 prevalence according to exposure level and the presence of respiratory diseases.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
110
Spirometry, plethysmography, FeNO test
25mL peripheral blood will be collected
Non-injected thoracic CT scan
Prevalence ratio of AACD146 between the exposed and non-exposed groups.
Time frame: At enrollment
AACD146 prevalence in patients with interstitial or neoplastic lung disease.
Time frame: At enrollment
AACD146 Prevalence by type of interstitial lung disease
Time frame: At enrollment
AACD146 Prevalence by type of histological type of lung cancer.
Time frame: At enrollment
Correlation between AACD146 and exposure duration and dose to silica
Time frame: At enrollment
Correlation between AACD146 and soluble CD146
Time frame: At enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.